BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27165007)

  • 1. Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease.
    Mallawaarachchi AC; Hort Y; Cowley MJ; McCabe MJ; Minoche A; Dinger ME; Shine J; Furlong TJ
    Eur J Hum Genet; 2016 Nov; 24(11):1584-1590. PubMed ID: 27165007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease.
    Ali H; Al-Mulla F; Hussain N; Naim M; Asbeutah AM; AlSahow A; Abu-Farha M; Abubaker J; Al Madhoun A; Ahmad S; Harris PC
    Sci Rep; 2019 Mar; 9(1):4141. PubMed ID: 30858458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype of autosomal dominant polycystic kidney disease in Malta.
    Ciantar N; Zahra G; Delicata J; Sammut F; Calleja-Agius J; Farrugia E; Said E
    Eur J Med Genet; 2024 Jun; 69():104934. PubMed ID: 38537868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting PKD1 variants in polycystic kidney disease patients by single-molecule long-read sequencing.
    Borràs DM; Vossen RHAM; Liem M; Buermans HPJ; Dauwerse H; van Heusden D; Gansevoort RT; den Dunnen JT; Janssen B; Peters DJM; Losekoot M; Anvar SY
    Hum Mutat; 2017 Jul; 38(7):870-879. PubMed ID: 28378423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitations.
    Qi XP; Du ZF; Ma JM; Chen XL; Zhang Q; Fei J; Wei XM; Chen D; Ke HP; Liu XZ; Li F; Chen ZG; Su Z; Jin HY; Liu WT; Zhao Y; Jiang HL; Lan ZZ; Li PF; Fang MY; Dong W; Zhang XN
    Gene; 2013 Mar; 516(1):93-100. PubMed ID: 23266634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing.
    Tan AY; Michaeel A; Liu G; Elemento O; Blumenfeld J; Donahue S; Parker T; Levine D; Rennert H
    J Mol Diagn; 2014 Mar; 16(2):216-28. PubMed ID: 24374109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing.
    Mallawaarachchi AC; Lundie B; Hort Y; Schonrock N; Senum SR; Gayevskiy V; Minoche AE; Hollway G; Ohnesorg T; Hinchcliffe M; Patel C; Tchan M; Mallett A; Dinger ME; Rangan G; Cowley MJ; Harris PC; Burnett L; Shine J; Furlong TJ
    Eur J Hum Genet; 2021 May; 29(5):760-770. PubMed ID: 33437033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of autosomal dominant polycystic kidney disease.
    Song X; Haghighi A; Iliuta IA; Pei Y
    Expert Rev Mol Diagn; 2017 Oct; 17(10):885-895. PubMed ID: 28724316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a whole genome amplification long-range PCR sequencing method for ADPKD genotyping of low-level DNA samples.
    Liu G; Tan AY; Michaeel A; Blumenfeld J; Donahue S; Bobb W; Parker T; Levine D; Rennert H
    Gene; 2014 Oct; 550(1):131-5. PubMed ID: 25010725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population data improves variant interpretation in autosomal dominant polycystic kidney disease.
    Mallawaarachchi AC; Furlong TJ; Shine J; Harris PC; Cowley MJ
    Genet Med; 2019 Jun; 21(6):1425-1434. PubMed ID: 30369598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease.
    Xu D; Mao A; Chen L; Wu L; Ma Y; Mei C
    Clin Chem; 2024 Jun; 70(6):841-854. PubMed ID: 38527221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
    Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
    Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PKD1 Mutations in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Kim H; Kim HH; Chang CL; Song SH; Kim N
    Lab Med; 2021 Mar; 52(2):174-180. PubMed ID: 32816041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.
    Rossetti S; Hopp K; Sikkink RA; Sundsbak JL; Lee YK; Kubly V; Eckloff BW; Ward CJ; Winearls CG; Torres VE; Harris PC
    J Am Soc Nephrol; 2012 May; 23(5):915-33. PubMed ID: 22383692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocker displacement amplification-based genetic diagnosis for autosomal dominant polycystic kidney disease and the clinical outcomes of preimplantation genetic testing.
    Lin T; Luo J; Yu H; Dong B; Zhang Q; Zhang W; Chen K; Xiang Y; Liu D; Huang G
    J Assist Reprod Genet; 2023 Apr; 40(4):783-792. PubMed ID: 36773205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.
    Kinoshita M; Higashihara E; Kawano H; Higashiyama R; Koga D; Fukui T; Gondo N; Oka T; Kawahara K; Rigo K; Hague T; Katsuragi K; Sudo K; Takeshi M; Horie S; Nutahara K
    PLoS One; 2016; 11(11):e0166288. PubMed ID: 27835667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of PCR conditions and design of exon-specific primers for the efficient molecular diagnosis of PKD1 mutations.
    Liu W; Chen M; Wei J; He W; Li Z; Sun X; Shi Y
    Kidney Blood Press Res; 2014; 39(6):536-45. PubMed ID: 25531466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease.
    Chang MY; Chen HM; Jenq CC; Lee SY; Chen YM; Tian YC; Chen YC; Hung CC; Fang JT; Yang CW; Wu-Chou YH
    J Hum Genet; 2013 Nov; 58(11):720-7. PubMed ID: 23985799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.